Scientists have discovered what they believe has the potential to prevent the onset of an aggressive and hard-to-treat form of rheumatoid arthritis - a condition that affects 700,000 adults in the UK.
Published in the Journal of Experimental Medicine, a team of immunologists from Cardiff University tread new ground in describing how an immune system protein -- interleukin-27 -- regulates the inflammatory process in lymphoid-rich rheumatoid arthritis, which causes the characteristic symptoms of swollen and painful joints.